ViroPharma to Broaden its Orphan Drug Portfolio with DuoCort Pharma Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 11 (Table of Contents)
Published: 7 Nov-2011
DOI: 10.3833/pdr.v2011.i11.1605 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
ViroPharma is hoping to expand its orphan drug portfolio by forging a deal to acquire Sweden’s DuoCort Pharma for up to SEK1080 M (US$165 M)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS